This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Sandoz Glimepiride recalled due to mislabelling of dosage strength on packaging
- Starting date:
- January 24, 2014
- Type of communication:
- Advisory
- Subcategory:
- Drugs
- Source of recall:
- Health Canada
- Issue:
- Product label update
- Audience:
- General Public
- Identification number:
- RA-37743
Issue
Products affected
What you should do
Who is affected
Report health or safety concerns
Media enquiries
Public enquiries
What Health Canada is doing
Issue
Sandoz Canada Inc., in consultation with Health Canada, is voluntarily recalling one lot of its health product, glimepiride, that is used to treat diabetes, due to the mislabelling of boxes. While the outer carton of the product is labelled as containing 1 mg tablets, the blister package inside may contain 2 mg tablets.
This potentially poses a serious risk to consumers as a greater than prescribed dose of glimepiride can cause hypoglycemia (low blood sugar). Elderly patients are at increased risk of hypoglycemia, and their symptoms may be harder to notice. Symptoms include weakness, drowsiness, blurred vision, headache, sweating and confusion. In extreme cases, hypoglycemia may cause loss of consciousness, seizures, or death.
No adverse reactions related to this problem have been reported to Health Canada or Sandoz Canada Inc.
Products affected
Sandoz glimepiride 1 mg and 2 mg
DIN 02269589 and 02269597, Lot (L) DM5336, Expiry date: 2014-12
What you should do
- If you are prescribed this drug, you should check the lot number of the outer package or the blister pack. The recalled product lot number is (L) DM5336.
- Consumers who have this lot in their possession should return the product to the place of purchase and receive replacement product.
- Consult your health care practitioner immediately if you believe you have used an incorrect dosage strength of this product.
- Report any adverse events using this product to Health Canada.
For more information:
More information is available from Sandoz Canada Inc. by calling 1 (800) 343-8839 or on their website at www.sandoz.ca.
Sandoz Canada Inc.
145 Jules Léger
Boucherville, Quebec J4B 7K8
Who is affected
Canadians who use this product, especially the elderly.
Report health or safety concerns
- Call toll-free at 1-866-234-2345
- Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
Media enquiries
Health Canada
(613) 957-2983
Public enquiries
(613) 957-2991
1-866 225-0709
What Health Canada is doing
Health Canada is monitoring the recall of the affected lot of Sandoz glimepiride.